Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Rekvina Laboratories Ltd

NSE: VINRKLB · BSE: 526075 · Pharmaceuticals & Biotechnology · 8 announcements

Share price
₹49.90
Market cap
₹30.08 Cr
Revenue (annual)
₹1.27 Cr
Net profit (annual)
₹-0.25 Cr
P/E (TTM)
-88.5×Sector 50.4×
Promoter holding
77.00%+35.70% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:48 IST BSE
Management Change

Rekvina Laboratories Management Change

Rekvina Laboratories Ltd announced a change in its registered office within the city and the resignation of its Managing Director, Mr. Amit Shah.

16:52 IST BSE
Management Change

Rekvina Laboratories Management Change

Mr. Amit Mukesh Shah has resigned as Managing Director and Director of Rekvina Laboratories Limited, effective September 11, 2026.

13:46 IST BSE
Other Announcement

Rekvina Laboratories Other Announcement

The company filed its shareholding pattern reporting changes in share distribution following the recent open offer. The public shareholding has fallen below the minimum threshold.

15:37 IST BSE
Board Meeting Outcome

Rekvina Laboratories Board Meeting Outcome

Rekvina Laboratories' board meeting approved the Annual Report for FY2025-26 and the notice for the upcoming AGM. It also noted the resignation of the Company Secretary.

15:32 IST BSE
Annual General Meeting

Rekvina Laboratories Annual General Meeting

Rekvina Laboratories' 38th AGM will be held online on September 29, 2026. The board also approved the notice and noted the company secretary's resignation.

19:36 IST BSE
Management Change

Rekvina Laboratories Management Change

Mr. Deepak Khandelwal has resigned from his position as Company Secretary and Compliance Officer of Rekvina Laboratories Limited, effective from September 2, 2026.